Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[Engineering memory-rich CAR-T cells by a piggyBac transposon system]Shigeki Yagyu
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2024
[Adoptive cell therapy for solid tumors]Kenichi Sakamoto, Shigeki Yagyu
International Journal of Clinical Oncology|March 1, 2023
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignanciesShigeki Yagyu, Yozo Nakazawa
BMJ Case Reports|January 1, 2022
Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based <i>MYCN</i> gene amplification analysis for risk stratificationMasaya Suematsu, Shigeki Yagyu, Hajime Hosoi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2015
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem CellsShigeki Yagyu, Valentina Hoyos, Francesca Del Bufalo, et al.
Molecular Therapy. Methods & Clinical Development|September 15, 2016
Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switchShigeki Yagyu, Valentina Hoyos, Francesca Del Bufalo, et al.
Biochemical and Biophysical Research Communications|October 24, 2022
Non-viral inducible caspase 9 mRNA delivery using lipid nanoparticles against breast cancer: An in vitro studyIkumi Nakashima, Shoji Saito, Eiichi Akahoshi, et al.
Pediatric Blood & Cancer|March 4, 2011
Detection of MYCN DNA in the cerebrospinal fluid for diagnosing isolated central nervous system relapse in neuroblastomaTomiko Kimoto, Masami Inoue, Sadao Tokimasa, et al.
Cancer Cell International|June 4, 2020
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cellsKazutaka Ouchi, Mitsuru Miyachi, Shigeki Yagyu, et al.
Frontiers in Immunology|February 14, 2022
<i>PiggyBac</i> Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic FunctionMasaya Suematsu, Shigeki Yagyu, Nobuyoshi Nagao, et al.
Pageof 7